The interleukin-1 (IL-1), IL-18, and IL-33 families of cytokines are related by their mechanisms of origin, receptor structure, and signal transduction pathways. All three cytokines are synthesized as precursor molecules and cleaved by caspase-1 before or during release from the cell. The NALP-3 inflammasome is crucial for generating active caspase-1. The IL-1 family includes two agonists (IL-1α and IL-1β), a specific inhibitor (IL-1Ra), and two receptors (IL-1RI and IL-1RII). IL-1RI and IL-33R both use the same accessory protein, IL-1RAcP. The balance between IL-1 and IL-1Ra is important in preventing disease, and excess IL-1 is implicated in many human diseases. The IL-18 family includes IL-18 and its inhibitor, IL-18BP. The IL-18 receptor is similar to the IL-1 receptor complex, including a single ligand-binding chain and a different accessory protein. IL-18 links innate and adaptive immune responses. IL-33 binds to the orphan IL-1 family receptor T1/ST2 and stimulates T-helper 2 responses and mast cells. The inflammasome is a molecular scaffold in the cytoplasm that contains caspase-1 and controls its activity. The NALP3 inflammasome is particularly important in human disease, as mutations in the NALP3 gene are associated with overproduction of IL-1. The mechanisms and regulation of IL-1β production are relevant to many inflammatory diseases. Two signals are required for IL-1β release from monocytes: TLR induction of pro-IL-1β transcription and NLR-induced processing and release through a caspase-1-dependent mechanism. Autoinflammatory diseases are characterized by overproduction of IL-1β and are linked to mutations in the CIAS1 gene. These diseases include NOMID, CINCA, MWS, and FCU. The NALP3 inflammasome is involved in the pathogenesis of these diseases. Uric acid and gout are related to the NALP3 inflammasome, as uric acid release from injured cells serves as an endogenous danger signal. IL-1β plays a key role in gout, and treatment with anakinra, an IL-1Ra molecule, has been effective in reducing IL-1β release. IL-1β is involved in various human diseases, including arthritis, pulmonary fibrosis, and diseases of the central nervous system. Anakinra has been beneficial in systemic-onset juvenile idiopathic arthritis and adult-onset Still's disease. IL-1β also plays a role in diabetes mellitus and cardiovascular diseaseThe interleukin-1 (IL-1), IL-18, and IL-33 families of cytokines are related by their mechanisms of origin, receptor structure, and signal transduction pathways. All three cytokines are synthesized as precursor molecules and cleaved by caspase-1 before or during release from the cell. The NALP-3 inflammasome is crucial for generating active caspase-1. The IL-1 family includes two agonists (IL-1α and IL-1β), a specific inhibitor (IL-1Ra), and two receptors (IL-1RI and IL-1RII). IL-1RI and IL-33R both use the same accessory protein, IL-1RAcP. The balance between IL-1 and IL-1Ra is important in preventing disease, and excess IL-1 is implicated in many human diseases. The IL-18 family includes IL-18 and its inhibitor, IL-18BP. The IL-18 receptor is similar to the IL-1 receptor complex, including a single ligand-binding chain and a different accessory protein. IL-18 links innate and adaptive immune responses. IL-33 binds to the orphan IL-1 family receptor T1/ST2 and stimulates T-helper 2 responses and mast cells. The inflammasome is a molecular scaffold in the cytoplasm that contains caspase-1 and controls its activity. The NALP3 inflammasome is particularly important in human disease, as mutations in the NALP3 gene are associated with overproduction of IL-1. The mechanisms and regulation of IL-1β production are relevant to many inflammatory diseases. Two signals are required for IL-1β release from monocytes: TLR induction of pro-IL-1β transcription and NLR-induced processing and release through a caspase-1-dependent mechanism. Autoinflammatory diseases are characterized by overproduction of IL-1β and are linked to mutations in the CIAS1 gene. These diseases include NOMID, CINCA, MWS, and FCU. The NALP3 inflammasome is involved in the pathogenesis of these diseases. Uric acid and gout are related to the NALP3 inflammasome, as uric acid release from injured cells serves as an endogenous danger signal. IL-1β plays a key role in gout, and treatment with anakinra, an IL-1Ra molecule, has been effective in reducing IL-1β release. IL-1β is involved in various human diseases, including arthritis, pulmonary fibrosis, and diseases of the central nervous system. Anakinra has been beneficial in systemic-onset juvenile idiopathic arthritis and adult-onset Still's disease. IL-1β also plays a role in diabetes mellitus and cardiovascular disease